ICS As Rescue Medication in Acute Asthma

Simple item page
dc.contributor.authorYorgancioglu, A
dc.date.accessioned2024-07-18T11:49:42Z
dc.date.available2024-07-18T11:49:42Z
dc.description.abstractAsthma guidelines address the issue of acute asthma exacerbation by recommending as the main therapeutic interventions oxygen, inhaled b2-agonists and systemic corticosteroids. These agents are undoubtedly effective, but are also associated with problems such as metabolic adverse effects. Inhaled corticosteroids (ICS) offer potential benefit in the acute setting because they are delivered directly to the airways. They are also likely to reduce systemic exposure, which would lead in turn to reductions in rates of unwanted systemic effects. In this manuscript, data on ICS as recue medication will be evaluated.
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/4217
dc.language.isoEnglish
dc.publisherMEDIMOND S R L
dc.subjectINHALED CORTICOSTEROIDS
dc.subjectORAL PREDNISONE
dc.subjectEXACERBATIONS
dc.subjectBUDESONIDE
dc.subjectFLUTICASONE
dc.subjectTHERAPY
dc.titleICS As Rescue Medication in Acute Asthma
dc.typeProceedings Paper

Files

Collections

Web of Science Koleksiyonu